"Streptococcus agalactiae" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A bacterium which causes mastitis in cattle and occasionally in man.
| Descriptor ID |
D013292
|
| MeSH Number(s) |
B03.353.750.737.872.100 B03.510.400.800.872.100 B03.510.550.737.872.100
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Streptococcus agalactiae".
Below are MeSH descriptors whose meaning is more specific than "Streptococcus agalactiae".
This graph shows the total number of publications written about "Streptococcus agalactiae" by people in this website by year, and whether "Streptococcus agalactiae" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Streptococcus agalactiae" by people in Profiles.
-
Follicular cystitis in urine cytology: A clinical and cytopathologic study. Diagn Cytopathol. 2019 Nov; 47(11):1223-1228.
-
Cystitis follicularis in bladder washings: report of two cases and review of the literature. Diagn Cytopathol. 2007 Aug; 35(8):537-8.
-
Pilot study to prevent early-onset Group B Streptococcal disease in newborns. Adv Neonatal Care. 2006 Aug; 6(4):208-19.
-
Alternative algorithms for prevention of perinatal group B streptococcal infections. Pediatr Infect Dis J. 1998 Nov; 17(11):973-9.
-
Prevention of early-onset neonatal group B streptococcal disease. Pediatrics. 1997 Jun; 99(6):866-9.
-
Neonatal group B streptococcal infections. Curr Opin Pediatr. 1995 Feb; 7(1):13-8.
-
Antimicrobial prophylaxis of neonatal group B streptococcal sepsis. Clin Perinatol. 1988 Dec; 15(4):831-50.
-
In vitro activity of A-56268 (TE-031), a new macrolide, compared with that of erythromycin and clindamycin against selected gram-positive and gram-negative organisms. Antimicrob Agents Chemother. 1987 Feb; 31(2):328-30.